edoc

Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas

Wild, Damian and Christ, Emanuel and Caplin, Martyn E. and Kurzawinski, Tom R. and Forrer, Flavio and Brändle, Michael and Seufert, Jochen and Weber, Wolfgang A. and Bomanji, Jamshed and Perren, Aurel and Ell, Peter J. and Reubi, Jean Claude. (2011) Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas. Journal of nuclear medicine, Vol. 52, H. 7. pp. 1073-1078.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6005901

Downloads: Statistics Overview

Abstract

Glucagon-like peptide-1 (GLP-1) receptor imaging is superior to somatostatin receptor subtype 2 (sst(2)) imaging in localizing benign insulinomas. Here, the role of GLP-1 and sst(2) receptor imaging in the management of malignant insulinoma patients was investigated.
Faculties and Departments:03 Faculty of Medicine > Bereich Querschnittsfächer (Klinik) > Radiologie USB > Nuklearmedizin (Wild)
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Querschnittsfächer (Klinik) > Radiologie USB > Nuklearmedizin (Wild)
UniBasel Contributors:Forrer, Flavio
Item Type:Article, refereed
Article Subtype:Research Article
Bibsysno:Link to catalogue
Publisher:Society of nuclear medicine
ISSN:0022-3123
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:25 Oct 2013 08:32
Deposited On:25 Oct 2013 08:32

Repository Staff Only: item control page